Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens
Since the discovery of penicillin by Alexander Fleming in 1929 as a therapeutic agent against staphylococci, β-lactam antibiotics (BLAs) remained the most successful antibiotic classes against the majority of bacterial strains, reaching a percentage of 65% of all medical prescriptions. Unfortunately...
Main Authors: | Corneliu Ovidiu Vrancianu, Irina Gheorghe, Elena-Georgiana Dobre, Ilda Czobor Barbu, Roxana Elena Cristian, Marcela Popa, Sang Hee Lee, Carmen Limban, Ilinca Margareta Vlad, Mariana Carmen Chifiriuc |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/22/8527 |
Similar Items
-
Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of <i>Acinetobacter baumannii</i>
by: Corneliu Ovidiu Vrancianu, et al.
Published: (2020-06-01) -
Retrospective Analysis on Antimicrobial Resistance Trends and Prevalence of β-lactamases in <i>Escherichia coli</i> and ESKAPE Pathogens Isolated from Arabian Patients during 2000–2020
by: Mahfouz Nasser, et al.
Published: (2020-10-01) -
Modulation of Quorum Sensing and Biofilms in Less Investigated Gram-Negative ESKAPE Pathogens
by: Veronica Lazar, et al.
Published: (2021-07-01) -
Eskapism : En analys av Edward Albees Who's Afraid of Virginia Woolf?
by: Svensson, Dan
Published: (2008) -
Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients
by: Hadir A. El-Mahallawy, et al.
Published: (2016-09-01)